

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
343 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 48.85 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 47.31 | Oscillator | Neutral |
| Williams %R (14) | -59.09 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.07 (Hist 0.02) | Oscillator | Strong Buy |
| Average Directional Index (14) | 22.86 (+DI 18.1 / -DI 27.5) | Trend | Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 24, 26 | Cavalcanti Guilherme Perboyre | officer: Global CFO and IRO | S-Sale | 183,501 @ $13.85 | $2.54M |
| EMA 20 | 12.49 | MA | Sell |
| SMA 20 | 12.30 | MA | Buy |
| EMA 50 | 12.58 | MA | Sell |
| SMA 50 | 12.67 | MA | Sell |
| SMA 200 | 14.15 | MA | Strong Sell |
| Jun 9, 26 |
| Cavalcanti Guilherme Perboyre |
| officer: Global CFO and IRO |
| A-Award |
| 112,098 |
| — |
| May 21, 26 | O'Callaghan Jeremiah Alphonsus | director | A-Award | 49,554 | — |
| May 21, 26 | O'Callaghan Jeremiah Alphonsus | director | A-Award | 27,228 | — |
| May 21, 26 | Cavalcanti Guilherme Perboyre | officer: Global CFO and IRO | A-Award | 185,828 | — |
| Mar 18, 26 | Tomazoni Gilberto | director, officer: Global Chief Executive Officer | 0 | — |
| Mar 18, 26 | Cavalcanti Guilherme Perboyre | officer: Global CFO and IRO | 0 | — |
| Mar 18, 26 | Cavalcanti Guilherme Perboyre | officer: Global CFO and IRO | 1,139,914 | — |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| EFFECT | Oct 22, 2026 | 2026-10-23 00:15:17 | View |
| 424B3 | Oct 22, 2026 | 2026-10-22 16:31:48 | View |
| F-4 | Oct 16, 2026 | 2026-10-16 16:31:32 | View |
| 8-K | Sep 15, 2026 | 2026-09-15 17:00:36 | View |
| 4 | Aug 25, 2026 | 2026-08-25 11:21:49 | View |
| 425 | Aug 19, 2026 | 2026-08-18 21:05:47 | View |
| 8-K | Aug 19, 2026 | 2026-08-18 21:04:08 | View |
| SC 13G/A | Aug 12, 2026 | 2026-08-12 17:08:10 | View |
| SC 13G | Aug 12, 2026 | 2026-08-12 12:08:01 | View |
| 8-K | Aug 11, 2026 | 2026-08-10 21:16:48 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
AMSTELVEEN, Netherlands--(BUSINESS WIRE)--JBS N.V. (NYSE: JBS; B3: JBSS32) announced today that it will release its third quarter 2026 financial results after the U.S. market closes on Monday, November 9, 2026. The company's executives will review the results on a conference call and webcast on Tuesday, November 10, 2026, at 9:00 a.m. Eastern Time (11:00 a.m. Brasília Time). Prepared remarks regarding the company's financial and operational results will be followed by a question-and-answer sess.
Assenagon Asset Management S.A. reduced its holdings in Jbs N.V. (NYSE: JBS) by 95.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 86,127 shares of the company's stock after selling 1,759,109 shares during the quarter. Assenagon Asset Management S.A.'s holdings in
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | 0.31 | 0.20 | Miss -35.0% | $23.90B |
| May 12, 2026 | 0.20 | 0.20 | Miss -2.2% | $21.61B |
| Feb 11, 2026 | 2.26 | 0.39 | Miss -82.7% | $23.06B |
| Nov 13, 2025 | 0.51 | 0.52 | Beat 2.6% | $22.60B |
| Aug 13, 2025 | 0.51 | 0.53 | Beat 4.5% | $21.90B |
| May 13, 2025 | 0.23 | 0.50 | Beat 111.8% | $20.45B |
FY2025 · 10-K disclosure
Current price $12.42
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 22, 26 | JP Morgan | maintain | Overweight | Overweight |
| Oct 9, 26 | JP Morgan | maintain | Overweight | Overweight |
| Aug 24, 26 | UBS | maintain | Buy | Buy |
| Aug 17, 26 | Stephens & Co. | maintain | Overweight | Overweight |
| Aug 12, 26 | JP Morgan | maintain | Overweight | Overweight |
| Jul 28, 26 | JP Morgan | upgrade | Neutral | Overweight |
| Jul 16, 26 | Barclays | maintain | Overweight | Overweight |
| Jun 29, 26 | JP Morgan | maintain | Neutral | Neutral |
| May 14, 26 | JP Morgan | maintain | Neutral | Neutral |
Annual filings (FY) with consensus forward estimates (hatched)
TTM vs. 5-year historical average (annual ratios)
| Metric | JBS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 16.5x | -1.2x · sector 38.2x | Discount |
| Forward P/E (FY26E) | 3.3x | EPS est. 3.75 | Discount |
| Price / Book | 8.1x | 3.5x | Elevated |
| Price / Sales | 0.4x | 0.4x | In line |
| EV / EBITDA | 5.2x | 8.2x | Discount |
| Return on equity | 17.7% | — | Healthy |
| Gross margin | 11.9% | 14.7% | Below hist. |
| Debt / Equity | 2.97 | 2.56 | Levered |
| Piotroski / Altman Z | 7/9 | Z 11.87 | Safe zone |
Discounted cash flow model